The future of treatment is taking shape—be there to help define it! Bringing science, technology, and policy into one conversation, the 14th WFH Global Forum on Advances and Access to Safe Treatment Products for Bleeding Disorders is a unique meeting that fosters open dialogue and collaboration across a range of different stakeholders. You can see all the sessions and speakers here.
This year’s program will explore a wide range of topics, from safety and surveillance to bias and gaps in women’s care, and the evolving treatment landscape for von Willebrand disease (VWD). It will also provide and in-depth look at rebalancing agents, the impact of artificial intelligence on hemophilia care, and access to gene therapy. Overarching themes of policy, procurement, and sustainability will be explored throughout the Forum, as these ultimately determine whether innovation can translate into real-world access for people with bleeding disorders worldwide. The event will conclude with a look at the next round of innovations, highlighting emerging strategies that continue to advance treatment options, supporting the WFH vision of Treatment for All.
Registration is now open! Don’t miss your chance to join this important global conversation: secure your spot in Montreal today by registering here.
The 14th edition of the WFH Global Forum is supported by funding from: CSL Behring, Pfizer, Sanofi, Sobi, with additional support from Biomarin.